Delmetacin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C18H15NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I9Q51XHI1K, chemically known as 1h-indole-3-acetic acid, 1-benzoyl-2-methyl- (9ci) but generally known as delmetacin, which bears US NIH Compound Identifier 27860. European Medicines Agency schedules Delmetacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06955MIG. The term DELMETACIN is an International Non-Proprietary Name. DELMETACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule delmetacin under HS 29339990 and SITC 51577. As of Q4 2014, DELMETACIN remains the US FDA Preferred Term for this commodity. Delmetacin bears US NLM identifiers UMLS ID C0618634 and NCI Concept Code C76801. SMILES: O=C(N1C(C(C2C1CCCC2)CC(=O)O)C)C1CCCCC1.